Agency for Healthcare Research and Quality (AHRQ), August 2009
Migraine With Aura Doubles Stroke RiskCMEIschemic stroke risk doubles in individuals with migraine with aura, especially in those who are women, young, smokers, or those receiving contraceptives containing estrogen.
Medscape Medical News CME, November 2009
Statins May Reduce Cancer Deaths in COPD Patients: StudyCMEIn a Dutch study, treatment with statins in patients with chronic obstructive pulmonary disease was associated with a reduced mortality risk from extrapulmonary cancer.
Risk Stratification in Hematologic MalignanciesCME/CEDrs. Kanti R. Rai and Steven E. Coutre address the latest risk stratification strategies for patients with a variety of hematologic malignancies.
NCCN - MedscapeCME Metastatic Colorectal Cancer Tumor BoardCME/CEIn this video roundtable, Drs. Alan Venook, Mary Mulcahy, and Michael Choti illustrate the process of treatment decision making as they "think through" 2 complex patient cases.
Anti-TNF Cycling: Impact on Patient OutcomesCMEGregg J. Silverman, MD, discusses anti-TNF cycling and impact on patient outcomes in this video interview with MedscapeCME Rheumatology.
Neurotoxins: Now and in the FutureCME/CEGary D. Monheit, MD, reviews the current landscape of aesthetic treatment with botulinum neurotoxin type A products.
MedscapeCME Psychiatry & Mental Health, August 2009
NCCN-Medscape Oncology Breast Cancer Tumor BoardCME/CEWatch and learn as a multidisciplinary panel of experts discusses treatment decisions for 2 patients: one with early, high-risk breast cancer and one with recurrent, metastatic disease.
New Developments in Aesthetic Therapy With Botulinum Neurotoxin ACME/CEHema A. Sundaram, MD, discusses how the approval of a new botulinum neurotoxin A for aesthetic use and the mandating of new safety labeling for all botulinum neurotoxins will affect treatment plans.
Life After Breast Cancer Treatment: The "New Normal"CMELearn from this expert roundtable discussion about how to recognize and address the concerns and needs -- medical, emotional, and psychological -- of women after breast cancer treatment.
Ongoing Challenges in Hepatitis B: Addressing Real-World IssuesCMETune in to this video roundtable discussion to hear Drs. Poordad, Saab, and Reau review the approved antiviral therapies for first-line treatment of HBV and factors contributing to underdiagnosis.